Siglec-5 as a novel receptor mediates endothelial cells oxLDL transcytosis to promote atherosclerosis

IF 6.4 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Xiong Jia , Xiangli Bai , Zhiqiang Yin , Qijun Zheng , Yin Zhao , Yajing Lu , Yan Shu , Yayu Wang , Yifei Zhang , Si Jin
{"title":"Siglec-5 as a novel receptor mediates endothelial cells oxLDL transcytosis to promote atherosclerosis","authors":"Xiong Jia ,&nbsp;Xiangli Bai ,&nbsp;Zhiqiang Yin ,&nbsp;Qijun Zheng ,&nbsp;Yin Zhao ,&nbsp;Yajing Lu ,&nbsp;Yan Shu ,&nbsp;Yayu Wang ,&nbsp;Yifei Zhang ,&nbsp;Si Jin","doi":"10.1016/j.trsl.2024.09.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Excessive subendothelial retention of oxidized low-density lipoprotein (oxLDL) and subsequent oxLDL engulfment by macrophages leads to the formation of foam cells and the development of atherosclerosis. Our previous study showed that the plasma level of sialic acid-binding immunoglobulin-like lectin 5 (Siglec-5) was a novel biomarker for the prognosis of atherosclerosis in diabetic patients. However, the role and underlying mechanisms of Siglec-5 in atherosclerosis have not been elucidated.</div></div><div><h3>Methods</h3><div>The interaction between oxLDL and Siglec-5 was detected by fluorescence colocalization and coimmunoprecipitation. The effect of oxLDL on Siglec-5 expression was detected in endothelial cells and macrophages, and the effect of Siglec-5 on oxLDL transcytosis and uptake was investigated. Siglec-5 was overexpressed in mice using recombinant adeno-associated virus vector serotype 9 (rAAV9-Siglec-5) to evaluate the effect of Siglec-5 on oxLDL uptake and atherogenesis <em>in vivo</em>. In addition, the effects of Siglec-5 antibodies and soluble Siglec-5 proteins on oxLDL transcytosis and uptake and their role in atherogenesis were investigated <em>in vivo</em> and <em>in vitro</em>.</div></div><div><h3>Results</h3><div>We found that oxLDL interacted with Siglec-5 and that oxLDL stimulated the expression of Siglec-5. Siglec-5 promotes the transcytosis and uptake of oxLDL, while both anti-Siglec-5 antibodies and soluble Siglec-5 protein attenuated oxLDL transcytosis and uptake. Interestingly, overexpression of Siglec-5 by recombinant adeno-associated viral vector serotype 9 (rAAV9-Siglec-5) promoted the retention of oxLDL in the aorta of C57BL/6 mice. Moreover, overexpression of Siglec-5 significantly accelerated the formation of atherosclerotic lesions in Apoe<sup>−/−</sup> mice. Moreover, both anti-Siglec-5 antibodies and soluble Siglec-5 protein significantly alleviated the retention of oxLDL in the aorta of rAAV9-Siglec-5-transfected C57BL/6 mice and the formation of atherosclerotic plaques in rAAV9-Siglec-5-transfected Apoe<sup>−/−</sup> mice.</div></div><div><h3>Conclusion</h3><div>Our results suggested that Siglec-5 was a novel receptor that mediated oxLDL transcytosis and promoted the formation of foam cells. Interventions that inhibit the interaction between oxLDL and Siglec-5, including anti-Siglec-5 antibody or soluble Siglec-5 protein treatment, may provide novel therapeutic strategies in treating atherosclerosis.</div></div>","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"274 ","pages":"Pages 49-66"},"PeriodicalIF":6.4000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1931524424001713","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Excessive subendothelial retention of oxidized low-density lipoprotein (oxLDL) and subsequent oxLDL engulfment by macrophages leads to the formation of foam cells and the development of atherosclerosis. Our previous study showed that the plasma level of sialic acid-binding immunoglobulin-like lectin 5 (Siglec-5) was a novel biomarker for the prognosis of atherosclerosis in diabetic patients. However, the role and underlying mechanisms of Siglec-5 in atherosclerosis have not been elucidated.

Methods

The interaction between oxLDL and Siglec-5 was detected by fluorescence colocalization and coimmunoprecipitation. The effect of oxLDL on Siglec-5 expression was detected in endothelial cells and macrophages, and the effect of Siglec-5 on oxLDL transcytosis and uptake was investigated. Siglec-5 was overexpressed in mice using recombinant adeno-associated virus vector serotype 9 (rAAV9-Siglec-5) to evaluate the effect of Siglec-5 on oxLDL uptake and atherogenesis in vivo. In addition, the effects of Siglec-5 antibodies and soluble Siglec-5 proteins on oxLDL transcytosis and uptake and their role in atherogenesis were investigated in vivo and in vitro.

Results

We found that oxLDL interacted with Siglec-5 and that oxLDL stimulated the expression of Siglec-5. Siglec-5 promotes the transcytosis and uptake of oxLDL, while both anti-Siglec-5 antibodies and soluble Siglec-5 protein attenuated oxLDL transcytosis and uptake. Interestingly, overexpression of Siglec-5 by recombinant adeno-associated viral vector serotype 9 (rAAV9-Siglec-5) promoted the retention of oxLDL in the aorta of C57BL/6 mice. Moreover, overexpression of Siglec-5 significantly accelerated the formation of atherosclerotic lesions in Apoe−/− mice. Moreover, both anti-Siglec-5 antibodies and soluble Siglec-5 protein significantly alleviated the retention of oxLDL in the aorta of rAAV9-Siglec-5-transfected C57BL/6 mice and the formation of atherosclerotic plaques in rAAV9-Siglec-5-transfected Apoe−/− mice.

Conclusion

Our results suggested that Siglec-5 was a novel receptor that mediated oxLDL transcytosis and promoted the formation of foam cells. Interventions that inhibit the interaction between oxLDL and Siglec-5, including anti-Siglec-5 antibody or soluble Siglec-5 protein treatment, may provide novel therapeutic strategies in treating atherosclerosis.
Siglec-5 作为一种新型受体介导内皮细胞 oxLDL 转运,促进动脉粥样硬化。
背景:氧化低密度脂蛋白(oxLDL)在内皮下的过度滞留以及随后被巨噬细胞吞噬导致泡沫细胞的形成和动脉粥样硬化的发展。我们之前的研究表明,血浆中的唾液酸结合免疫球蛋白样凝集素 5(Siglec-5)水平是糖尿病患者动脉粥样硬化预后的新型生物标志物。然而,Siglec-5在动脉粥样硬化中的作用和内在机制尚未阐明:方法:通过荧光共聚焦和共沉淀技术检测了 oxLDL 与 Siglec-5 之间的相互作用。方法:通过荧光共聚焦和共免疫沉淀检测了 oxLDL 与 Siglec-5 之间的相互作用,检测了内皮细胞和巨噬细胞中 oxLDL 对 Siglec-5 表达的影响,并研究了 Siglec-5 对 oxLDL 转运和摄取的影响。利用重组腺相关病毒载体血清型9(rAAV9-Siglec-5)在小鼠体内过表达Siglec-5,以评估Siglec-5对体内oxLDL摄取和动脉粥样硬化的影响。此外,还在体内和体外研究了Siglec-5抗体和可溶性Siglec-5蛋白对oxLDL转运和摄取的影响及其在动脉粥样硬化发生中的作用:结果:我们发现oxLDL与Siglec-5相互作用,并且oxLDL刺激Siglec-5的表达。Siglec-5能促进oxLDL的转囊和摄取,而抗Siglec-5抗体和可溶性Siglec-5蛋白都能减少oxLDL的转囊和摄取。有趣的是,通过重组腺相关病毒载体血清型 9(rAAV9-Siglec-5)过表达 Siglec-5 可促进 oxLDL 在 C57BL/6 小鼠主动脉中的滞留。此外,Siglec-5 的过表达明显加速了载脂蛋白/-小鼠动脉粥样硬化病变的形成。此外,抗Siglec-5抗体和可溶性Siglec-5蛋白都能明显减轻氧化LDL在转染rAAV9-Siglec-5的C57BL/6小鼠主动脉中的滞留以及转染rAAV9-Siglec-5的载脂蛋白-/-小鼠动脉粥样硬化斑块的形成:我们的研究结果表明,Siglec-5 是一种新型受体,可介导 oxLDL 转运并促进泡沫细胞的形成。抑制 oxLDL 与 Siglec-5 之间相互作用的干预措施,包括抗 Siglec-5 抗体或可溶性 Siglec-5 蛋白治疗,可能为治疗动脉粥样硬化提供新的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Translational Research
Translational Research 医学-医学:内科
CiteScore
15.70
自引率
0.00%
发文量
195
审稿时长
14 days
期刊介绍: Translational Research (formerly The Journal of Laboratory and Clinical Medicine) delivers original investigations in the broad fields of laboratory, clinical, and public health research. Published monthly since 1915, it keeps readers up-to-date on significant biomedical research from all subspecialties of medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信